Q3 2024 Paysign Inc Earnings Call Transcript
Key Points
- PaySign Inc (PAYS) reported a 23% increase in revenue for the third quarter of 2024 compared to the same period in 2023, reaching $15.3 million.
- The company's adjusted EBITDA rose by 20.6% to $2.8 million, or 5 cents per fully diluted share, indicating improved profitability.
- Gross margins improved significantly, increasing by 440 basis points to 55.5% compared to the previous year, driven by the expansion of the patient affordability business.
- Revenue from the patient affordability business grew by an impressive 219% year over year, marking the fourth consecutive quarter of triple-digit growth.
- The company successfully onboarded several new programs, including a cornerstone account with one of the world's largest pharmaceutical companies, positioning it for continued growth into 2025.
- The plasma donor compensation business faced challenges due to hurricanes and staffing shortages, affecting operations and resulting in a slight decrease in revenue per center.
- Operating expenses increased by 35.6% to $7.8 million, with significant investments in personnel and technology impacting profitability.
- The company experienced a modest decline in the average monthly revenue per plasma center, attributed to external factors such as weather and staffing issues.
- Legal expenses related to the settlement of class action and derivative lawsuits are expected to impact financials in the fourth quarter.
- Despite strong growth in the patient affordability segment, the company faces challenges in maintaining consistent revenue per program due to the variability in program types and claim volumes.
Good afternoon. My name is Kevin and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Paysign. Inc third quarter, 2024 earnings conference call after the speaker's remarks. There will be a question and answer session as a reminder, this conference is being recorded.
If you'd like to be placed into question. Q you may press star one at any time.
The comments on today's call regarding paysign's financial results will be on a GAAP basis. Unless otherwise noted, Paysign's earnings release will be disseminated to the SEC earlier today and can be found on the investor relations section of our website paysign dotcom which includes reconciliations of non gapp measures to GAAP reported amounts additionally as set forth in more detail in our earnings release.
I'd like to remind everyone that today's call will include forward-looking statements regarding Paysign's future performance. Actual performance could differ materially from these forward-looking statements, information about the factors that could affect future performance to summarize at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
